OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Chien-liang Lin

3 Projects | 1 Researchers | $640,164 Invested

2016

Ohio State University

Chien-liang Lin, PhD

Development of small molecule activators of glutamate transporter EAAT2 translation for AD (Year Three- bridge funding)

  • Funding Amount: $176,156
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2015

Ohio State University

Chien-liang Lin, PhD

Development of small molecule activators of glutamate transporter EAAT2 translation for AD (year two)

  • Funding Amount: $244,008
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2013

Ohio State University

Chien-liang Lin, PhD

Development of small molecule activators of glutamate transporter EAAT2 translation for Alzheimer's disease

  • Funding Amount: $220,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed